MATE Act Training Requirement
With the passing of the Medication Access and Training Expansion (MATE) Act in December 2022, a new one-time training requirement went into effect for DEA registrants.
- This one-time requirement is for eight hours of accredited training related to the treatment and management of patients with opioid or other substance use disorders.
- You must attest to having fulfilled the requirement the first time that you renew your DEA registration on or after June 27, 2023.
- Read about how you can fulfill the requirement below, or review full details in the Letter to DEA Registered Practitioners.
How can you fulfill the requirement?
If you are board certified in addiction medicine or addiction psychiatry, you are deemed to have fulfilled the requirement.
If you graduated in good standing from a medical (allopathic or osteopathic), dental, physician assistant, or advanced practice nursing school in the United States within five years of June 27, 2023, and successfully completed a comprehensive curriculum that included at least eight hours of training on the following criteria, you are deemed to have fulfilled the requirement:
- Treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all drugs approved by the Food and Drug Administration for the treatment of a substance use disorder; or
- Safe pharmacological management of dental pain and screening, brief intervention, and referral for appropriate treatment of patients with or at risk of developing opioid and other substance use disorders.
Complete a total of eight hours of accredited training on treatment and management of patients with opioid or other substance use disorders. (Training providers must be accredited through one of the approved accredited groups*.)
- The training does not have to occur in one session. It can be cumulative across multiple sessions that equal eight hours of training.
- Past trainings can count towards the requirement, even if you completed the training prior to the enactment of this new training obligation on December 29, 2022.
- Past DATA waiver trainings (prescriber training for the use of buprenorphine for opioid use disorder) count towards the requirement.
- Trainings can occur in a variety of formats, including classroom settings, seminars at professional society meetings, or virtual offerings.
*Approved accredited groups listed below:
|
Accredited Training Sponsored by University of Iowa Carver College of Medicine
Accredited Training Sponsored by University of Iowa
Carver College of Medicine
Rounding@IOWA: Maternal Substance Use Disorders
- CME podcast available to all learners - listen where you get your podcasts
- CE credit is free for UI faculty, staff, and adjuncts - HawkID required